Fertilization Methods: IVF vs. ICSI
- Sakshi Goswami
- Aug 11
- 2 min read

Fertilization is a cornerstone of the IVF process, where sperm meets the oocyte to form a zygote. This blog compares the two primary fertilization methods used in ART: conventional IVF and intracytoplasmic sperm injection (ICSI).
Conventional IVF
Process: Sperm and oocytes are co-cultured in a petri dish, allowing sperm to fertilize the egg naturally.
Suitability: Ideal for patients with normal sperm parameters and no severe male factor infertility.
Advantages: Mimics natural fertilization, is less invasive, and avoids potential risks associated with micromanipulation.
Intracytoplasmic Sperm Injection (ICSI)
Process: A single sperm is injected directly into the cytoplasm of a mature oocyte using a microneedle.
Suitability: Preferred for severe male factor infertility, low sperm count or motility, or previous IVF failures.
Advantages: Ensures fertilization even with limited or poor-quality sperm.
Comparing IVF and ICSI
Parameter | IVF | ICSI |
Fertilization Method | Natural sperm-egg fusion | Direct sperm injection |
Indications | Normal sperm parameters | Severe male factor infertility |
Cost | Lower | Higher |
Success Rates | Variable, based on sperm quality | Higher in severe male infertility cases |
Factors Influencing Method Choice
Sperm Quality: ICSI is often the preferred method for abnormal sperm parameters.
Patient History: Previous fertilization failures may warrant the use of ICSI.
Cost and Resources: IVF is less expensive and may be suitable for couples with no significant male factor infertility.
Clinical Outcomes
Both methods have high success rates when applied to the appropriate patient population. However, ICSI is often favored for its ability to overcome fertilization barriers.
References
Palermo, G., et al. (1992). Intracytoplasmic sperm injection: a novel treatment for all forms of male infertility. The Lancet, 340(8810), 17-18. Link
Bhattacharya, S., et al. (2001). Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. The Lancet, 357(9274), 2075-2079. Link
Comments